| P/E (FY) | 20.1 | Sales (TTM) | €253.5M |
| Earnings (TTM) | €10.1M | ROE | 7.58% |
| Net Margin | 3.98% | ROIC | 7.04% |
| Debt / Equity | 0.64 | TD / EBITDA | 2.48 |
| EPS Growth 3Y | — | Sales Growth 3Y | 6.76% |
Fine Foods & Pharmaceuticals N.T.M. S.p.A. provides contract manufacturing and development of oral solid forms for the pharmaceutical and nutraceutical industries in Italy. Its output includes pharmaceuticals, dietary supplements, and medical devices in formats such as powders, film-coated and chewable tablets, effervescent tablets, capsules, and liquid sachets, along with cosmetics including toothpastes, mouthwashes, skin care, deodorants, body cleansers, hair products, and perfumery items. The company was founded in 1984 and is based in Verdellino, Italy.
| Market Cap | — | Trading Days | 2428 |
| 52W High | 11.90 |
| 52W Low | 7.62 |
| % Off High | −30.76% |
| YTD | −12.50% | 1Y | 4.78% |
| 3Y | 8.36% | 5Y | −33.73% |
| Since incept. (ann.) | −0.81% |
| Ann. Volatility (1Y) | 34.83% | Ann. Volatility (3Y) | 28.20% |
| Sharpe (1Y) | 0.32 | Sharpe (3Y) | 0.24 |
| Max Drawdown (1Y) | −31.65% | Max Drawdown (3Y) | −31.65% |
| Beta (3Y, vs SPY) | 0.65 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| KO | COCA COLA CO | $379.78B | 29.0 |
| PM | Philip Morris International Inc. | $311.99B | 27.6 |
| PEP | PEPSICO INC | $194.99B | 23.8 |
| CVS | CVS HEALTH Corp | $139.51B | 78.7 |
| MO | ALTRIA GROUP, INC. | $124.94B | 18.2 |
| MNST | Monster Beverage Corp | $95.59B | — |
| MDLZ | Mondelez International, Inc. | $80.20B | 33.1 |
| 2914.T | JAPAN TOBACCO INC. | $79.69B | 22.7 |
| CTVA | Corteva, Inc. | $59.49B | 55.6 |
| KDP | Keurig Dr Pepper Inc. | $42.29B | 20.3 |
| HSY | HERSHEY CO | $41.04B | — |
| ADM | Archer-Daniels-Midland Co | $40.09B | 37.3 |
